Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Michael C. Campbell, MD, FAPA, FAAFP
PCC
Case Report
Recurrent Use of Implantable Buprenorphine
December 5, 2019
The FDA has approved buprenorphine implants for 1 year of total use or 2 sets of implants. This case demonstrates successful use of implantable buprenorphine past 1 year.
Michael C. Campbell
PCC
Letter to the Editor
Hyponatremia and Central Pontine Myelinolysis as a Result of Beer Potomania: A Case Report
August 26, 2010
Michael C. Campbell
